Page 18 - Read Online

Rajput Cyclical nutritional therapy clinical trial

Ann Dermatol 2012;24:243-52. 48. Rajendrasingh JR. Role of non androgenic factors in hair loss and hair
28. Bahta AW, Farjo N, Farjo B, Philpott MP. Premature senescence of regrowth. J Cosmo Trichol 2017;3:118.
balding dermal papilla cells in vitro is associated with p16(INK4a) 49. Rajput R. The concept of cyclical nutritional therapy for hair growth
expression. J Invest Dermatol 2008;128:1088-94. which can be applied for wellness. J Nutr Food Sci 2017;7:615.
29. Harrison S, Sinclair R. Telogen effluvium. Clin Exp Dermatol 50. Roughead ZK, Zito CA, Hunt JR. Inhibitory effects of dietary calcium
2002;27:389-95. on the initial uptake and subsequent retention of heme and nonheme
30. Ustuner ET. Cause of androgenic alopecia: crux of the matter. Plast iron in humans: comparisons using an intestinal lavage method. Am J
Reconstr Surg Glob Open 2013;1:e64. Clin Nutr 2005;82:589-97.
31. Kaufman KD. Androgens and alopecia. Mol Cell Endocrinol 51. Brown EB Jr, Dubach R, Moore CV. Studies in iron transportation
2002;198:89-95. and metabolism. XI. Critical analysis of mucosal block by large doses
32. Sawaya ME, Price VH. Different levels of 5alpha-reductase type I and of inorganic iron in human subjects. J Lab Clin Med 1958;52:335-55.
II, aromatase, and androgen receptor in hair follicles of women and 52. Halliwell B. Antioxidants in human health and disease. Annu Rev Nutr
men with androgenetic alopecia. J Invest Dermatol 1997;109:296-300. 1996;16:33-50.
33. Chen W, Thiboutot D, Zouboulis CC. Cutaneous androgen 53. Halliwell B. The antioxidant paradox. Lancet 2000;355:1179-80.
metabolism: basic research and clinical perspectives. J Invest 54. Wang L, Li Q, Duan XL, Chang YZ. Effects of extracellular iron
Dermatol 2002;119:992-1007. concentration on calcium absorption and relationship between
34. Hoffmann R, Happle R. Current understanding of androgenetic Ca2+ and cell apoptosis in Caco-2 cells. World J Gastroenterol
alopecia. Part II: clinical aspects and treatment. Eur J Dermatol 2005;11:2916-21.
2000;10:410-7. 55. Meydani M. Antioxidants in the prevention of chronic diseases. Nutr
35. Inadomi T. Efficacy of finasteride for treating patients with Clin Care 2002;5:47-9.
androgenetic alopecia who are pileous in other areas: a pilot study in 56. Rutkowski M, Grzegorczyk K. Adverse effects of antioxidative
japan. Indian J Dermatol 2014;59:163-5. vitamins. Int J Occup Med Environ Health 2012;25:105-21.
36. Price VH, Roberts JL, Hordinsky M, Olsen EA, Savin R, Bergfeld 57. Barzel US, Massey LK. E Excess dietary protein can adversely affect
W, Fiedler V, Lucky A, Whiting DA, Pappas F, Culbertson J, Kotey bone. J Nutr 1998;128:1051-3.
P, Meehan A, Waldstreicher J. Lack of efficacy of finasteride in 58. Linkswiler HM, Zemel MB, Hegsted M, Schuette S. Protein-induced
postmenopausal women with androgenetic alopecia. J Am Acad hypercalciuria. Fed Proc 1981;40:2429-33.
Dermatol 2000;43:768-76. 59. Kerstetter JE, Allen LH. Dietary protein increases urinary calcium. J
37. Kaufman KD, Olsen EA, Whiting D, Savin R, DeVillez R, Bergfeld Nutr 1990;120:134-6.
W, Price VH, Van Neste D, Roberts JL, Hordinsky M, Shapiro J, 60. Itoh R, Nishiyama N, Suyama Y. Dietary protein intake and urinary
Binkowitz B, Gormley GJ. Finasteride in the treatment of men with excretion of calcium: a cross-sectional study in a healthy Japanese
androgenetic alopecia. Finasteride male pattern hair loss study group. population. Am J Clin Nutr 1998;67:438-44.
J Am Acad Dermatol 1998;39:578-89. 61. Everts HB. Endogenous retinoids in the hair follicle and sebaceous
38. Irwig MS. Persistent sexual side effects of finasteride: could they be gland. Biochim Biophys Acta 2012;1821:222-9.
permanent? J Sex Med 2012;9:2927-32. 62. Foitzik K, Spexard T, Nakamura M, Halsner U, Paus R. Towards
39. Traish AM, Hassani J, Guay AT, Zitzmann M, Hansen ML. Adverse dissecting the pathogenesis of retinoid-induced hair loss: all-trans
side effects of 5α-reductase inhibitors therapy: persistent diminished retinoic acid induces premature hair follicle regression (catagen)
libido and erectile dysfunction and depression in a subset of patients. by upregulation of transforming growth factor-beta2 in the dermal
J Sex Med 2011;8:872-84. papilla. J Invest Dermatol 2005;124:1119-26.
40. Eun HC. The involvement of ROS on androgen inducible TGF beta 1 63. Finner AM. Nutrition and hair: deficiencies and supplements.
regulation derived from dermal papilla cells; a suggestive implication Dermatol Clin 2013;31:167-72.
of ROS on androgenetic alopecia. J Am Academy Dermatol 64. Rushton DH. Nutritional factors and hair loss. Clin Exp Dermatol
2008;58:AB84. 2002;27:396-404.
41. Shin H, Yoo HG, Inui S, Itami S, Kim IG, Cho AR, Lee DH, Park 65. Guo EL, Katta R. Diet and hair loss: effects of nutrient deficiency and
WS, Kwon O, Cho KH, Won CH. Induction of transforming growth supplement use. Dermatol Pract Concept 2017;7:1-10.
factor-beta 1 by androgen is mediated by reactive oxygen species in 66. Eritsland J. Safety considerations of polyunsaturated fatty acids. Am J
hair follicle dermal papilla cells. BMB Rep 2013;46:460-4. Clin Nutr 2000;71:S197-201.
42. Trüeb RM. Molecular mechanisms of androgenetic alopecia. Exp 67. Harper AE. Origin of recommended dietary allowances--an historic
Gerontol 2002;37:981-90. overview. Am J Clin Nutr 1985;41:140-8.
43. Goette DK, Odom RB. Alopecia in crash dieters. JAMA 68. Spirichev VB. Scientific rationale for the use of vitamins in the
1976;235:2622-3. prophylactic and therapeutic purposes. Report 1. Lack of vitamins
44. Betsy A, Binitha M, Sarita S. Zinc deficiency associated with in the diet of modern human: reasons, consequences and correction.
hypothyroidism: an overlooked cause of severe alopecia. Int J Trichol Vopr Pitan 2010;79:4-14. (in Russian)
2013;5:40-2. 69. Beer C, Wood S, Veghte RH. A clinical trial to investigate the effect
45. Ozturk P, Kurutas E, Ataseven A, Dokur N, Gumusalan Y, Gorur A, of Cynatine HNS on hair and nail parameters. ScientificWorldJournal
Tamer L, Inaloz S. BMI and levels of zinc, copper in hair, serum and 2014;2014:641723.
urine of Turkish male patients with androgenetic alopecia. J Trace 70. Rizer RL, Stephens TJ, Herndon JH, Sperber BR, Murphy J, Ablon
Elem Med Biol 2014;28:266-70. GR. A marine protein-based dietary supplement for subclinical hair
46. Jaworsky C, Kligman AM, Murphy GF. Characterization of thinning/loss: results of a multisite, double-blind, placebo-controlled
inflammatory infiltrates in male pattern alopecia: implications for clinical trial. Int J Trichology 2015;7:156-66.
pathogenesis. Br J Dermatol 1992;127:239-46. 71. Nichols AJ, Hughes OB, Canazza A, Zaiac MN. An open-label
47. Young JW, Conte ET, Leavitt ML, Nafz MA, Schroeter AL. Cutaneous evaluator blinded study of the efficacy and safety of a new nutritional
immunopathology of androgenetic alopecia. J Am Osteopath Assoc supplement in androgenetic alopecia: a pilot study. J Clin Aesthet
1991;91:765-71. Dermatol 2017;10:52-6.
172 Plastic and Aesthetic Research ¦ Volume 4 ¦ September 30, 2017